Prophylactic Sildenafil in Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Pilot Randomized, Double-Blinded, Placebo-Controlled Trial

BACKGROUND: Bronchopulmonary dysplasia (BPD) is the need for oxygen therapy at 36 weeks postmenstrual age (PMA). Sildenafil has been shown to enhance the lung alveolarization and vascularization in newborn animal models after lung injury and has possible therapeutic potential for the prevention of B...

Descripción completa

Detalles Bibliográficos
Autores principales: Abounahia, Fouad F., Abu-Jarir, Rawia, Abounahia, Mohamed F., Al-Badriyeh, Daoud, Abushanab, Dina, Abu-Ghalwa, Mahmoud, Mansour, Ashraf, Kurdi, Bader, Al-Rifai, Hilal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800408/
https://www.ncbi.nlm.nih.gov/pubmed/31414269
http://dx.doi.org/10.1007/s40261-019-00834-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800408/
https://www.ncbi.nlm.nih.gov/pubmed/31414269
http://dx.doi.org/10.1007/s40261-019-00834-0

Ejemplares similares